Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dursun

Showing results (11-20 of 190) with videos related to

Pageof 19
Sort By:
Journal of Psychopharmacology (Oxford, England)|February 12, 2010
A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosisPaul Fallon, Serdar M Dursun
Journal of Psychopharmacology (Oxford, England)|March 3, 2010
Schizophrenia genes, epigenetics and psychoneuroimmunology therapeutics: all make sense now?Norbert Müller, Serdar M Dursun
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 1, 2000
Clozapine weight gain, plus topiramate weight lossS M Dursun, S Devarajan
Lancet (London, England)|November 10, 2000
Nitric oxide in neonatesS M Dursun, H Robertson
Journal of Psychopharmacology (Oxford, England)|June 29, 2005
Olanzapine plus venlafaxine in treatment-resistant depressionS Devarajan, S M Dursun
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|July 20, 2000
Citalopram plus reboxetine in treatment-resistant depressionS Devarajan, S M Dursun
Medical Hypotheses|May 26, 1999
Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future researchS M Dursun, S Kutcher
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 26, 2001
Accelerated weight loss after treating refractory depression with fluoxetine plus topiramate: possible mechanisms of action?S M Dursun, S Devarajan
Journal of Psychiatry & Neuroscience : JPN|August 11, 2001
When treating patients with schizophrenia, what clinical points should be considered if lamotrigine is chosen to augment clozapine?S M Dursun, S Devarajan
Journal of Psychopharmacology (Oxford, England)|January 5, 2002
Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case-series outcome studyS M Dursun, J F Deakin
Pageof 19

Showing results (11-20 of 190) with videos related to

Sort By:
Pageof 19
Journal of Psychopharmacology (Oxford, England)|February 12, 2010
A naturalistic controlled study of relapsing schizophrenic patients with tardive dyskinesia and supersensitivity psychosisPaul Fallon, Serdar M Dursun
Journal of Psychopharmacology (Oxford, England)|March 3, 2010
Schizophrenia genes, epigenetics and psychoneuroimmunology therapeutics: all make sense now?Norbert Müller, Serdar M Dursun
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 1, 2000
Clozapine weight gain, plus topiramate weight lossS M Dursun, S Devarajan
Lancet (London, England)|November 10, 2000
Nitric oxide in neonatesS M Dursun, H Robertson
Journal of Psychopharmacology (Oxford, England)|June 29, 2005
Olanzapine plus venlafaxine in treatment-resistant depressionS Devarajan, S M Dursun
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|July 20, 2000
Citalopram plus reboxetine in treatment-resistant depressionS Devarajan, S M Dursun
Medical Hypotheses|May 26, 1999
Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future researchS M Dursun, S Kutcher
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|April 26, 2001
Accelerated weight loss after treating refractory depression with fluoxetine plus topiramate: possible mechanisms of action?S M Dursun, S Devarajan
Journal of Psychiatry & Neuroscience : JPN|August 11, 2001
When treating patients with schizophrenia, what clinical points should be considered if lamotrigine is chosen to augment clozapine?S M Dursun, S Devarajan
Journal of Psychopharmacology (Oxford, England)|January 5, 2002
Augmenting antipsychotic treatment with lamotrigine or topiramate in patients with treatment-resistant schizophrenia: a naturalistic case-series outcome studyS M Dursun, J F Deakin
Pageof 19